IN8bio

+$0.04 (+1.57%) Today
$0.00 (0.00%) As of 8:23 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S.

CEO
William T. Ho
Employees
19
Headquarters
New York, New York
Founded
2016

INAB Key Statistics

Market cap
48.60M
Price-Earnings ratio
—
Dividend yield
—
Average volume
23.80K
High today
$3.01
Low today
$2.45
Open price
$2.45
Volume
6.12K
52 Week high
$10.32
52 Week low
$2.00

INAB Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.33 per share
Actual
-$0.33 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure